Merck (MRK) came out with a quarterly loss of $2.06 per share versus the Zacks Consensus Estimate of a loss of $2.17. This compares to earnings of $1.87 per share a year ago. These figures are adjusted for non-recurring items.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,